Somatostatin Inhibits the Production of Interferon-γ by Intestinal Epithelial Cells During Intestinal Ischemia–Reperfusion in Macaques
暂无分享,去创建一个
Chengwei Tang | Ling Liu | Bin Hu | Chunhui Wang | Q. Tan | Hao Wu
[1] M. Netea,et al. Bacterial translocation in an experimental model of multiple organ dysfunctions. , 2013, The Journal of surgical research.
[2] M. Huber. Microfilaments make mast cells migrate (rather than degranulate) , 2013, European journal of immunology.
[3] Z. Xia,et al. Mast cells activation contribute to small intestinal ischemia reperfusion induced acute lung injury in rats. , 2012, Injury.
[4] A. Van Gossum,et al. Gut failure in the ICU. , 2011, Seminars in respiratory and critical care medicine.
[5] Alexander A. Morgan,et al. Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma. , 2011, The Journal of clinical investigation.
[6] R. Gopal,et al. Regulation of chemokine responses in intestinal epithelial cells by stress and Toxoplasma gondii infection , 2011, Parasite immunology.
[7] L. Voltaggio,et al. Mast cells in gastrointestinal disease. , 2010, Gastroenterology & hepatology.
[8] C. Dejong,et al. Gastrointestinal , Hepatobiliary and Pancreatic Pathology Human Intestinal Ischemia-Reperfusion – Induced Inflammation Characterized Experiences from a New Translational Model , 2010 .
[9] Linheng Li,et al. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. , 2010, Immunity.
[10] Chengwei Tang,et al. Somatostatin Limits Intestinal Ischemia-Reperfusion Injury in Macaques via Suppression of TLR4-NF-κB Cytokine Pathway , 2009, Journal of Gastrointestinal Surgery.
[11] C. Coopersmith,et al. INTESTINAL CROSSTALK: A NEW PARADIGM FOR UNDERSTANDING THE GUT AS THE "MOTOR" OF CRITICAL ILLNESS , 2007, Shock.
[12] M. Neurath,et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue , 2007, Nature Protocols.
[13] Christopher B Wilson,et al. Regulation of interferon-gamma during innate and adaptive immune responses. , 2007, Advances in immunology.
[14] T. Okanoue,et al. Interferon‐gamma is causatively involved in experimental inflammatory bowel disease in mice , 2006, Clinical and experimental immunology.
[15] Chengwei Tang,et al. AMELIORATION OF THE DEVELOPMENT OF MULTIPLE ORGAN DYSFUNCTION SYNDROME BY SOMATOSTATIN VIA SUPPRESSION OF INTESTINAL MUCOSAL MAST CELLS , 2005, Shock.
[16] R. Liu,et al. Increased activity of the intestinal mucosal mast cells in rats with multiple organ failure. , 2004, Chinese journal of digestive diseases.
[17] J. Macfie. Current status of bacterial translocation as a cause of surgical sepsis. , 2004, British medical bulletin.
[18] A. Grützkau,et al. Interleukin-6 enhances whereas tumor necrosis factor alpha and interferons inhibit integrin expression and adhesion of human mast cells to extracellular matrix proteins. , 2003, The Journal of investigative dermatology.
[19] P. Vergara,et al. Somatostatin inhibits intestinal mucosal mast cell degranulation in normal conditions and during mast cell hyperplasia , 2003, Regulatory Peptides.
[20] A. Stadnyk. Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. , 2002, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[21] L. Hültner,et al. Mast cells and inflammation. , 2002, Archivum immunologiae et therapiae experimentalis.
[22] L. Lefrançois,et al. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer's patch, and lamina propria cells. , 2001, Current protocols in immunology.
[23] G. Locke,et al. American Gastroenterological Association Medical Position Statement: guidelines on constipation. , 2000, Gastroenterology.
[24] American Gastroenterological Association Medical Position Statement: guidelines on intestinal ischemia. , 2000, Gastroenterology.
[25] O. Rotstein. Pathogenesis of multiple organ dysfunction syndrome: gut origin, protection, and decontamination. , 2000, Surgical infections.
[26] Gilchrist,et al. Interferon‐γ regulates the interaction of RBL‐2H3 cells with fibronectin through production of nitric oxide , 1999, Immunology.
[27] S. Fan,et al. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. , 1999, Gastrointestinal endoscopy.
[28] J. Coleman,et al. Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-gamma-induced suppression of exocytosis. , 1997, Journal of immunology.
[29] T. Nakahata,et al. Interferon‐γ promotes the survival and FcεRI‐mediated histamine release in cultured human mast cells , 1996, Immunology.
[30] E. Bissonnette,et al. Interferons differentially regulate histamine and TNF-alpha in rat intestinal mucosal mast cells. , 1995, Immunology.
[31] M. Arock,et al. Specific high‐affinity receptors for interferon‐γ on mouse bone marrow‐derived mast cells: inhibitory effect of interferon‐γ on mast cell precursors , 1990 .
[32] M. Arock,et al. Specific high-affinity receptors for interferon-gamma on mouse bone marrow-derived mast cells: inhibitory effect of interferon-gamma on mast cell precursors. , 1990, European journal of immunology.